Medicare Enrolled

Dr. Serena Mraz, M.D.

Procedural Dermatology Physician · Vallejo, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
2290 SACRAMENTO ST, Vallejo, CA 94590
7076435785
In practice since 2006 (19 years)
NPI: 1518911395 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Mraz from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Mraz? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Mraz

Dr. Serena Mraz is a procedural dermatology physician in Vallejo, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Mraz performed 3,738 Medicare services across 1,599 unique beneficiaries.

Between the years covered by Open Payments, Dr. Mraz received a total of $603,941 from 36 pharmaceutical and/or device companies across 1049 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in procedural dermatology physician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Mraz is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 43% volume in CA $603,941 industry payments

Medicare Practice Summary

Medicare Utilization ↗
3,738
Medicare services
Top 43% in CA for procedural dermatology physician
1,599
Unique beneficiaries
$56
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~197 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Destruction of precancerous skin growths, 2-14
This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer.
1,297 $6 $9
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
592 $68 $120
Additional skin growth biopsy
Removal of a sample of an additional skin growth for laboratory examination. This code is used for each extra lesion biopsied during the same session.
386 $48 $90
Skin biopsy, tangential
A procedure to remove a sample of the first identified skin growth for laboratory examination.
366 $84 $167
Destruction of precancerous skin growth, 1
Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer.
315 $41 $108
Steroid injection (triamcinolone)
A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered.
123 $1 $2
Dexamethasone injection (steroid)
An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram.
96 $0 $2
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
64 $93 $174
Destruction of 15 or more precancerous skin growths
This procedure involves the removal or destruction of fifteen or more precancerous skin lesions. It is performed to treat abnormal skin cells that have the potential to develop into cancer.
61 $148 $252
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
58 $45 $74
Destruction of cancer skin growth, 0.6-1.0 cm
This procedure involves the removal or destruction of a cancerous skin growth located on the trunk, arms, or legs that measures between 0.6 and 1.0 centimeters.
46 $114 $241
Destruction of cancer skin growth, 1.1-2.0 cm
Removal of a cancerous skin growth on the trunk, arms, or legs that measures between 1.1 and 2.0 centimeters.
46 $131 $292
Ultrasound of arm or leg veins
An ultrasound exam of the veins in the arm or leg. The test uses sound waves to check blood flow and may include compression and other maneuvers.
43 $163 $339
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
42 $9 $28
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
41 $82 $173
Ultrasound of arm or leg veins
An ultrasound exam of the veins in one arm or leg using compression and other maneuvers to assess blood flow and check for blockages.
36 $114 $210
Destruction of skin growths (warts/lesions), 1-14
This procedure involves the removal or destruction of one to fourteen skin growths. It is a minor surgical intervention performed on the skin surface.
27 $91 $188
Radiofrequency vein destruction, first vein
A procedure to treat the first incompetent vein in the arm or leg using radiofrequency energy and imaging guidance.
21 $1,037 $2,646
Laser vein destruction with imaging guidance
This procedure uses laser energy to destroy a faulty vein in the arm or leg. Imaging guidance is used to ensure accurate placement during the treatment.
21 $919 $2,186
Injection into skin growths, 1-7
A procedure involving the injection of medication into one to seven skin growths.
19 $32 $90
Topical aminolevulinic acid HCl 20% solution
A topical medication applied to the skin for medical treatment. It is supplied as a single-unit dosage form containing 354 mg of the active ingredient.
14 $307 $405
Light therapy to destroy precancerous skin growth
A qualified healthcare professional applies light to the skin to destroy precancerous growths.
13 $203 $355
Intermediate wound repair, 2.6-7.5 cm
A medical procedure to close a wound on the scalp, underarms, trunk, arms, or legs that measures between 2.6 and 7.5 centimeters. This type of repair involves cleaning the wound and stitching it closed to promote healing.
11 $274 $507
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$603,941
Total received (2018-2024)
Avg $86,277/year across 7 years
Top 1% in CA for procedural dermatology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
36
Companies
1,049
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$578,737 (95.8%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$19,019 (3.1%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,186 (1.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$73,746
2023
$14,445
2022
$90,709
2021
$99,275
2020
$65,294
2019
$126,408
2018
$134,063

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Galderma Laboratories, L.P.
$70,249
ABBVIE INC.
$2,301
Ortho Dermatologics, a division of Bausch Health US, LLC
$279
GENZYME CORPORATION
$250
Novartis Pharmaceuticals Corporation
$220
Solta Medical, a division of Bausch Health US, LLC
$132
Janssen Biotech, Inc.
$125
PFIZER INC.
$41
UCB, Inc.
$32
Fresenius Kabi USA, LLC
$32
Sandoz Inc.
$24
Incyte Corporation
$24
Regeneron Healthcare Solutions, Inc.
$23
LEO Pharma Inc.
$15
Top 3 companies account for 98.8% of 2024 payments
All-time payments by company (2018-2024) ›
Galderma Laboratories, L.P.
$306,328
AbbVie, Inc.
$98,275
Novartis Pharmaceuticals Corporation
$63,234
Allergan, Inc.
$60,283
Allergan Inc.
$29,554
AbbVie Inc.
$19,605
Celgene Corporation
$12,346
ABBVIE INC.
$3,075
E.R. Squibb & Sons, L.L.C.
$3,012
Amgen Inc.
$1,558
Helsinn Therapeutics (U.S.), Inc.
$1,503
Janssen Biotech, Inc.
$1,135
Janssen Scientific Affairs, LLC
$730
GENZYME CORPORATION
$513
Biofrontera Inc.
$493
Ortho Dermatologics, a division of Bausch Health US, LLC
$482
Sun Pharmaceutical Industries Inc.
$348
PFIZER INC.
$238
ModernaTX, Inc.
$188
Solta Medical, a division of Bausch Health US, LLC
$176
Lilly USA, LLC
$167
UCB, Inc.
$136
Regeneron Healthcare Solutions, Inc.
$109
STRATA Skin Sciences, Inc.
$90
Fresenius Kabi USA, LLC
$87
LEO Pharma Inc.
$54
Incyte Corporation
$50
Osiris Therapeutics Inc.
$29
Sandoz Inc.
$24
Merz North America, Inc.
$23
MERZ NORTH AMERICA, INC.
$21
Dermavant Sciences, Inc.
$19
Arrow International, Inc.
$17
SUN PHARMACEUTICAL INDUSTRIES INC.
$16
Boston Scientific Corporation
$15
Vascular Insights, LLC
$10
Top 3 companies account for 77.5% of all-time payments
Associated products mentioned in payments ›
ADBRY · AKLIEF · Ameluz · BOTOX · BOTOX COSMETIC · Bimzelx · CIBINQO · COSENTYX · Cabtreo · Cimzia · Clarivein · DERMATITIS - DISEASE · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · Dermatological Psoriasis and Vitiligo Treatment · EUCRISA · Enbrel · HUMIRA · HYRIMOZ · Humira · IDACIO · ILUMYA · ILUMYA (tildrakizumab-asmn) injection · LIBTAYO · OPZELURA · Otezla · REMICADE · RINVOQ · SILIQ · SKYRIZI · Skyrizi · Sotyktu · Stravix · TALTZ · TREMFYA · Tremfya · VALCHLOR · VTAMA · Varithena Administration Pack · Vein Treatment - Other Products · Winlevi · XEOMIN · XTRAC
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (96%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in procedural dermatology physician and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for procedural dermatology physician in CA.

Looking for a procedural dermatology physician in Vallejo?
Compare procedural dermatology physicians in the Vallejo area by procedure volume, costs, and industry payment transparency.
Browse procedural dermatology physicians nearby

Geographic Context

Procedural dermatology physicians within 10 mi
9
Per 100K population
2.0
County median income
$99,994
Nearest hospital
ADVENTIST HEALTH VALLEJO
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Mraz is a clinical cardiology specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 1% of CA peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Mraz experienced with destruction of precancerous skin growths, 2-14?
Based on Medicare claims data, Dr. Mraz performed 1,297 destruction of precancerous skin growths, 2-14 services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Mraz receive payments from pharmaceutical companies?
Yes. Dr. Mraz received a total of $603,941 from 36 companies across 1,049 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Mraz's costs compare to other procedural dermatology physicians in Vallejo?
Dr. Mraz's average Medicare payment per service is $56. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Mraz) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →